Go With the Flow: MOR(E) to Ketamine Than NMDA Receptor Antagonism
American Journal of Psychiatry · 01.06.2026 · 183 (6) · 376-378
DOI: 10.1176/appi.ajp.20260275 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Psychiatry, erschienen am 01.06.2026. Verfasst von Michael Michaelides. Beteiligte Einrichtung: Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, NIDA Intramural Research Program, Baltimore. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biobehavioral Imaging and Molecular Neuropsychopharmacology Section, NIDA Intramural Research Program, Baltimore.
Zitieren
APA
Michaelides, M. (2026). Go With the Flow: MOR(E) to Ketamine Than NMDA Receptor Antagonism. American Journal of Psychiatry, 183(6), 376-378. https://doi.org/10.1176/appi.ajp.20260275
Vancouver
Michaelides M. Go With the Flow: MOR(E) to Ketamine Than NMDA Receptor Antagonism. American Journal of Psychiatry. 2026;183(6):376-378. doi:10.1176/appi.ajp.20260275
BibTeX
@article{Michaelides2026,
author = {Michaelides, Michael},
title = {Go With the Flow: MOR(E) to Ketamine Than NMDA Receptor Antagonism},
journal = {American Journal of Psychiatry},
year = {2026},
volume = {183},
number = {6},
pages = {376--378},
doi = {10.1176/appi.ajp.20260275}
}
EUVIMED